Research update: 2015 Grant Awarded to CINCINNATI Children's Hospital

In 2015, $50,000 was granted to Cincinnati Children's Hospital Histiocytosis Research Program with funds raised by HLH Supporters in 2014.

Identifying Small Molecule Enhancers of Cytotoxic Lymphocyte Killing in Patients with HLH
Progress Report, November 2015: Our laboratory is interested in taking an entirely novel approach to develop new drugs that act as enhancers of Natural Killer (NK) and Cytotoxic T cell (CTL) function in patients with HLH.